Virtual Medicinal Product (VMP)
-
Insulin glulisine 100units/ml solution for injection 10ml vials
Name Details
Current Name
Insulin glulisine 100units/ml solution for injection 10ml vials
|
Start Date
14-09-2005
|
End Date
|
|
Abbreviated Name
Insulin glulisine 100units/ml inj 10ml vials
|
Start Date
01-05-2009
|
|
Insulin glulisine 100units/ml soln for inj 10ml vials |
Previous Start Date
14-09-2005
|
Previous End Date
30-04-2009
|
Unit Dose & Form Information
- DF Indicator
- Discrete
- UDFS Indicator
- 10.0
- UDFS UOM
- ml
- Unit Dose UOM
- vial
Summary
- Prescribing Status
- Valid as a prescribable product
- Controlled Drug Category
- No Controlled Drug Status
- Route
- Subcutaneous
- Form
- Solution for injection
- Ontology Form/Route
- solutioninfusion.subcutaneous, solutioninjection.subcutaneous
- Name Basis
- rINN - Recommended International Non-proprietary
Codes
- ATC Code
-
A10AB06
BNF |
Current BNF
06010101
|
Start Date
04-04-2022
|
End Date
|
Previous BNF
06010101
|
Start Date
03-05-2006
|
End Date
03-04-2022
|
SNOMED Codes
Code
|
Start Date
|
End Date
|
36047211000001100 |
29-10-2018 |
|
412448008 |
15-09-2005 |
28-10-2018 |
VMP Ingredients
Name
Insulin glulisine
Basis of strength description
Based on Ingredient Substance
BOSS
Strength and UOM (Nmr)
100.0
Strength and UOM (Dmr)
1.0
Virtual Medicinal Product Pack (VMPP) Information
1 vial |
1600 |
Part VIIIA Category C |